|
Setidegrasib Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: ASP3082
Duarte, California1 trial
A Study of ASP3082 in Adults With Advanced Solid Tumors
City of Hope National Medical Center
Phase 1
Jacksonville, Florida1 trial
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Baptist MD Anderson Cancer Institute
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.